Sign In  |  Register  |  About Menlo Park  |  Contact Us

Menlo Park, CA
September 01, 2020 1:28pm
7-Day Forecast | Traffic

  • Search Hotels in Menlo Park

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about Phase 2 Trial

Recent news which mentions Phase 2 Trial

< Previous 1 2 3 4 5 6 7 8 9 Next >
ALX Oncology's Evorpacept Data Fails To Impress At ASH Presentation
Tickers ALXO
Tags why it's moving Briefs News
From Benzinga
Viracta Therapeutics Posts Data From Lymphoma Trial At ASH Presentation
Tickers VIRX
Tags Movers News Briefs
From Benzinga
Harpoon Shares Jump After Early Data From BCMA-Targeting Myeloma Candidate At ASH Meet
Tickers HARP
Tags Briefs News ASH21
From Benzinga
JNJ's Janssen Posts Two Years Survival Data On BCMA Cell Therapy In Multiple Myeloma
Tickers JNJ LEGN
Tags Market News Phase 2 Trial Benzinga
From Benzinga
Jazz Posts New Data for ALL/LBL Treatment At ASH 2021 Annual Meeting
Tickers JAZZ
Tags Health Care General Phase 3 Trial
From Benzinga
Roche Uncorks Favorable Responses From Mosunetuzumab In Follicular Lymphoma Settings
Tickers RHHBF RHHBY RHHVF
Tags Benzinga Market News Phase 2 Trial
From Benzinga
Bluebird Bio Posts Updated Data From Sickle Cell Gene Therapy Program
Tickers BLUE
Tags BLUE General Sickle Cell Disease
From Benzinga
Merus Shares Updated Data From Zeno Triplet Combo Data In Breast Cancer Settings
Tickers MRUS
Tags breast cancer General Movers
From Benzinga
Infinity Pharma Shares Updated Eganelisib Combo Therapy In Breast Cancer Trial
Tickers BMY INFI RHHBF RHHBY
Tags RHHVF RHHBF breast cancer
From Benzinga
Moderna Posts Data From Early mRNA Flu Vaccine Study, Pivotal Trial On Its Way
Tickers BNTX MRNA SNY
Tags influenza General Movers
From Benzinga
Roche Posts Encouraging Follow-up Data From Tiragolumab/Tecentriq Trial In Lung Cancer
Tickers RHHBF RHHBY RHHVF
Tags Health Care Biotech Benzinga
From Benzinga
Angion's ANG-3777 Faces Third Failure In 2021, This Time Flunks Acute Kidney Injury Trial
Tickers ANGN
Tags Market News Phase 2 Trial Penny Stocks
From Benzinga
Innate Pharma Says Chemo-Free Monalizumab Triplet Therapy Shows Preliminary Anti-Cancer Activity
Tickers AZN AZNCF IPHA
Tags Biotech Small Cap AZN
From Benzinga
Johnson & Johnson Posts Additional RSV Vaccine Data
Tickers JNJ
Tags Phase 2 Trial Market News JNJ
From Benzinga
Ideaya Reports New Data From Combo Therapy Regime In Pretreated Eye Cancer Patients
Tickers IDYA
Tags General Briefs News
From Benzinga
Prometheus Biosciences Posts Phase 1 Data On Lead Therapeutic Candidate
Tickers RXDX
Tags News Briefs Movers
From Benzinga
Bellicum Secures $35M Via Equity Funding, Posts Interim Data From Early GoCAR-T Cancer Studies
Tickers BLCM
Tags Health Care Offerings Phase 1 Trial
From Benzinga
Ocular Therapeutix's Dexamethasone Ophthalmic Insert Meets Primary Goal In Dry Eye Disease Trial
Tickers OCUL
Tags General OCUL Movers
From Benzinga
GH Research Posts Data From Treatment-Resistant Depression Trial
Tickers GHRS
Tags Biotech Small Cap depression treatment
From Benzinga
Bolt Biotherapeutics Reveals Early Data From BDC-1001 Immuno-Oncology Candidate
Tickers BOLT
Tags General Movers Briefs
From Benzinga
Molecular Partners' Ensovibep Shows Early Safety Profile In COVID-19
Tickers MOLN
Tags Phase 2 Trial Market News Benzinga
From Benzinga
Stoke Touts Early Signs Of Efficacy For Antisense Drug In Dravet Syndrome
Tickers STOK
Tags epilepsy Health Care STOK
From Benzinga
Kazia Unveils Final Data From Mid-Stage Paxalisib Data In Newly Diagnosed Glioblastoma Patients
Tickers KZIA
Tags Health Care Brain Tumor KZIA
From Benzinga
Xenon Stock Jumps On New Encouraging Data From Epilepsy Treatment
Tickers XENE
Tags Movers Briefs News
From Benzinga
SQZ Biotechnologies' Cell Therapy Shows Favorable Safety Profile In HPV+ Solid Tumors
Tickers SQZ
Tags Movers News Briefs
From Benzinga
ARCA Biopharma Expects Data Readout From Mid-Stage COVID-19 Trial In Q1 2022
Tickers ABIO
Tags Benzinga Penny Stocks Phase 2 Trial
From Benzinga
FDA Signs Off Chemomab's Lead Candidate Mid-Stage Study In Bile Duct Disease
Tickers CMMB
Tags Briefs News Movers
From Benzinga
VBI Vaccines Reveals Updated Overall Survival Data From Brain Cancer Vaccine Trial
Tickers GSK VBIV
Tags Movers Briefs News
From Benzinga
Inhibrx Precision Cancer Antibody Receives FDA Orphan Drug Tag For Rare Bone Cancer
Tickers INBX
Tags News Briefs General
From Benzinga
Clene's Amyotrophic Lateral Sclerosis Candidate Shows Favorable Impact On Disease Progression
Tickers CLNN
Tags Trading Ideas Benzinga Market News
From Benzinga
< Previous 1 2 3 4 5 6 7 8 9 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 MenloPark.com & California Media Partners, LLC. All rights reserved.